INmune Bio at Cell 2026
Nov 12–13, 2026 London, UK ~800 attendees Website
INmune Bio takes part in 3 sessions at Cell 2026 in London. Its sessions focus on making cell therapies at scale so they reach patients, and on linking upstream and downstream processing. It also traces the long road of mesenchymal stromal cell therapies toward commercial approval.
| Organization | Cell 2026 Attendance |
|---|---|
INmune Bio Boca Raton, Florida | |
Clinical-stage company developing immune-targeted therapies, including a TNF inhibitor for neurological disease and an umbilical cord MSC therapy. | Talk Thu Nov 12 9:25am–9:50am Designing Large Scale Cell Therapies For Real-World Access Cell and gene therapyManufacturing and CMC Panel Fri Nov 13 1:55pm–2:20pm Closing The Gap: Connecting Upstream And Downstream Bioprocessing In Cell-Based Therapies Cell culture and upstream processingCell and gene therapy Talk Fri Nov 13 4:40pm–5:05pm MSC Therapies: From Decades Of Challenges To Commercial Approval Cell and gene therapyStem cells, organoids and cell models |
Instantly find 20 buyers from INmune Bio
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Cell 2026 or its organizers. Submit a correction